FDA
WASHINGTON, D.C. — In a Constituent Update posted yesterday, the Food and Drug Administration commented on the Feb. 4 report from the U.S. House of Representatives Committee on Oversight and Reform Subcommittee on Economic and Consumer Policy.
Since the report was posted, baby food companies such as Gerber have been hit with class-action lawsuits.
The FDA's response, which can be read in full here, highlights the following:
- How FDA regulations and monitoring help to ensure the safety of baby foods sold or manufactured in the United States.
- How when toxic elements in food present a potential health concern, the FDA takes steps to reduce levels, such as using science to set action levels, making data public, and working with industry on identifying effective mitigation strategies.
How the FDA is continuing to work to ensure both domestic and imported foods meet the same standards for toxic elements.
Latest from Quality Assurance & Food Safety
- FDA, CDC Investigate Salmonella Outbreak Linked to Live It Up Dietary Supplement Powder
- USDA FSIS Announces New Deputy Administrator of Field Operations
- ProVeg Incubator Launches Fast-Track to Impact Program for Alt-Protein Startups
- Kerry Releases 2026 Global Taste Charts
- FDA Shares Australia Certificate Requirements for Bivalve Molluscs and Related Products
- FDA Announces Update from CFIA on Certificate Requirements for Certain Meat, Poultry Products
- NIMA Partners Introduces the Next-Generation NIMA Gluten Sensor
- IFT to Host Community Conversation on Dietary Guidelines for Americans, 2025-2030 Report